Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albany Molecular Research Inc (NASDAQ:AMRI)

16.28
Delayed Data
As of 3:59pm ET
 -0.11 / -0.67%
Today’s Change
12.45
Today|||52-Week Range
20.65
-17.98%
Year-to-Date
The Cheapest Stocks in Biotech
Sep 23 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close16.39
Today’s open16.39
Day’s range16.13 - 16.45
Volume236,125
Average volume (3 months)252,882
Market cap$702.6M
Dividend yield--
Data as of 3:59pm ET, 09/29/2016

Growth & Valuation

Earnings growth (last year)+30.00%
Earnings growth (this year)+11.81%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+45.48%
P/E ratioNM
Price/Sales1.64
Price/Book2.03

Competitors

 Today’s
change
Today’s
% change
AMRNAmarin Corporation P...-0.11-3.40%
ARWRArrowhead Pharmaceut...+0.26+3.69%
RGNXRegenxbio Inc-0.49-3.41%
BSTCBiospecifics Technol...-2.04-4.35%
Data as of 4:00pm ET, 09/29/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)$0.18
Annual revenue (last year)$402.4M
Annual profit (last year)-$2.3M
Net profit margin-0.57%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
William S. Marth
Chief Operating Officer
George Svokos
Corporate headquarters
Albany, New York

Forecasts

Search for Jobs